Popular Pre-Market Trades in US Stocks

Mastec is up 7.85% in pre-market trading. There are no significant recent news; trading is active with clear capital flow. Considering the sector and industry trends, the stock shows notable volatility, and the specific reasons need further observation. no_news

Astera Labs is up 4.99% in pre-market trading. Based on recent news,

1. On July 27, Astera Labs' stock price rose 1.88%, mainly due to high market expectations for its future earnings. According to Benzinga Pro data, Astera Labs' stock price at the time of release was $297.06.

2. On July 29, Astera Labs' stock price fell 7.77%, with technical indicators showing weakened buying momentum. The MACD is below the signal line, and the negative histogram indicates a decline in buying momentum, with the stock price at the time of release being $260.56.

3. On July 29, analysts had high expectations for Astera Labs' financial report on August 4, which may determine whether the stock price pullback is a buying opportunity. The market has high expectations for Astera Labs' future earnings, while technical indicators show weakened buying momentum.

Top Gainers in Pre-Market Trading for US Stocks

Nuwellis is up 127.51% in pre-market trading. Based on recent key news:

1. On July 27, Nuwellis reported a preliminary revenue growth of 14% for the second quarter of 2026, driving a significant increase in stock price. The company stated that this growth is mainly due to the commercial success of the Aquadex ultrafiltration platform. Source: Reuters

2. On July 27, Nuwellis announced a 20% year-on-year revenue growth for the first half of 2026, further boosting market confidence. Source: Public Technologies

3. On July 27, Nuwellis plans to release its complete second-quarter financial results on August 13, with optimistic market expectations. Source: Public Technologies The medical device industry is experiencing strong growth, and the market is optimistic.

T3 Defense is up 71.25% in pre-market trading. Based on recent key news:

1. On July 29, T3 Defense surged 81.56% during the trading session, currently reported at $23.785. This sharp increase is mainly driven by both technical and fundamental factors. The company's completed 1-for-125 reverse stock split has compressed the float to 1.12 million shares, triggering a technical short squeeze. Additionally, the company has made operational progress in its Project 35 in the anti-drone technology field and achieved contract delivery. X S.E. Security and Defense Ltd. acquired a 16.67% stake in the company in exchange for equity in Project 35, further boosting market confidence

2. On July 30, T3 Defense's stock price rose by 88%, currently reported at $45.12. The stock exhibits characteristics of "small float + high trading volume," leading to significant price fluctuations.

3. On July 28, T3 Defense's subsidiary Industrial Techno-Logic Solutions completed the delivery of an automated composite production line to a major Israeli manufacturer, with a contract amount of $1.1 million. At the same time, the company holds a 60% stake in Project 35, further expanding its influence in the high-demand anti-drone technology sector. SEC Schedule 13D filings show that defense investor X S.E. Security and Defense Ltd. acquired 16.67% of T3 Defense's common stock. Demand in the defense technology sector is strong, and market confidence is rising.

China Su Xuan Tang Pharmaceutical, pre-market up 49.33%, has no significant news recently. Trading is active, with clear capital flow. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation